Markets:

Overview

News

Currencies

International

Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

29.36 -0.10 (-0.32%)

Streaming Delayed Price Updated: 2:41 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

41 Stocks Moving In Monday's Mid-Day Session ↗

November 15, 2021

Gainers Casper Sleep Inc. (NYSE: CSPR) shares climbed 87.1% to $6.64 after the company agreed to be acquired by Durational Capital Management. The company also reported Q3...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 15, 2021

Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) stock increased by 44.96% to $20.31 during Monday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

TG Therapeutics, inc (TGTX) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

TGTX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Earnings Scheduled For May 10, 2021 ↗

May 10, 2021

Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021 ↗

November 15, 2021

Upgrades For Targa Resources Corp (NYSE:

Via Benzinga

Emotions Wreak Havoc On Healthcare Investments ↗

October 16, 2021

If you buy shares of a stock like Target, of course you want the company to prosper. But let’s face it, you probably don’t get that excited about the same-store sales report each month. But when you...

Via Talk Markets

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 22, 2021

Gainers Regencell Bioscience (NASDAQ:

Via Benzinga

The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight ↗

September 19, 2021

Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical...

Via Benzinga

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold ↗

September 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (...

Via Benzinga

The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs ↗

September 12, 2021

Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week. Humanigen, Inc. (NASDAQ: HGEN) was among the biggest...

Via Benzinga

Understanding TG Therapeutics's Unusual Options Activity ↗

August 16, 2021

TG Therapeutics (NASDAQ:TGTX) shares experienced unusual options activity on Monday. The stock price moved down to $22.62 following the option alert. Sentiment: BEARISH Option...

Via Benzinga

Looking into TG Therapeutics's Return on Capital Employed ↗

August 13, 2021

After pulling data from Benzinga Pro it seems like during Q2, TG Therapeutics (NASDAQ:TGTX) posted sales of $1.54 million. Earnings were up 13.36%, but TG Therapeutics still...

Via Benzinga

TG Therapeutics, inc (TGTX) Q2 2021 Earnings Call Transcript ↗

August 04, 2021

TGTX earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

61 Biggest Movers From Yesterday ↗

August 03, 2021

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company announced a $5 million stock repurchase program....

Via Benzinga

Why TG Therapeutics Shares Are Trading Lower Today ↗

August 02, 2021

TG Therapeutics Inc (NASDAQ: TGTX) is trading lower Monday after the company announced worse-than-expected second-quarter financial results and H.C. Wainwright lowered its...

Via Benzinga

TG Therapeutics Stock Plunged As H.C. Wainwright Cuts Target Price After Disappointing Q2 ↗

August 02, 2021

H.C. Wainwright has lowered TG Therapeutics Inc's (NASDAQ:

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Gains 50 Points; Marin Software Shares Plummet ↗

August 02, 2021

Toward the end of trading Monday, the Dow traded up 0.02% to 34,941.69 while the NASDAQ rose 0.37% to 14,727.42. The S&P also rose, gaining 0.10% to 4,399.45. The U.S. has the...

Via Benzinga

Topics Stocks

Here's Why TG Therapeutics Stock Is Getting Hammered Today ↗

August 02, 2021

A second-quarter earnings report reminded investors how difficult it is for independent companies to launch new cancer drugs.

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 02, 2021

Gainers Xenetic Biosciences (NASDAQ:XBIO) stock increased by 35.01% to $5.5 during Monday's regular session. Trading volume for Xenetic Biosciences's stock is 10.1...

Via Benzinga

Mid-Day Market Update: Crude Oil Down 2.5%; Exicure Shares Spike Higher ↗

August 02, 2021

Midway through trading Monday, the Dow traded up 0.35% to 35,058.26 while the NASDAQ rose 0.52% to 14,748.83. The S&P also rose, gaining 0.39% to 4,412.29. The U.S. has the...

Via Benzinga

Topics Stocks

40 Stocks Moving In Monday's Mid-Day Session ↗

August 02, 2021

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares jumped 133% to $5.27 after the company announced a $5 million stock repurchase program. Exicure, Inc. (NASDAQ:...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Global Payments Posts Upbeat Q2 Earnings ↗

August 02, 2021

Following the market opening Monday, the Dow traded up 0.58% to 35,138.90 while the NASDAQ rose 0.40% to 14,731.03. The S&P also rose, gaining 0.46% to 4,415.36. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 29, 2021

Gainers Brickell Biotech (NASDAQ:BBI) stoc...

Via Benzinga

Earnings Scheduled For August 2, 2021 ↗

August 02, 2021

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is estimated to report earnings for its second quarter. • Addex Therapeutics (NASDAQ:ADXN) is...

Via Benzinga

Looking Into TG Therapeutics's Return On Capital Employed ↗

June 23, 2021

During Q1, TG Therapeutics's (NASDAQ:TGTX) reported sales totaled $793.00 thousand. Despite a 2.07% in earnings, the company posted a loss of $88.73 million. In Q4, TG...

Via Benzinga

Return On Capital Employed Overview: TG Therapeutics ↗

June 07, 2021

In Q1, TG Therapeutics (NASDAQ:TGTX) posted sales of $793.00 thousand. Earnings were up 2.07%, but TG Therapeutics still reported an overall loss of $88.73 million. In Q4, TG...

Via Benzinga

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗

May 31, 2021

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...

Via Benzinga

TG Therapeutics' Ublituximab-Umbralisib Combo Application Under FDA Review for Hematological Malignancies ↗

May 25, 2021

The FDA has accepted for review TG Therapeutics Inc's (NASDAQ: TGTX) marketing application seeking approval for ublituximab in combination with Ukoniq (...

Via Benzinga

TG Therapeutics Inc (TGTX) Q1 2021 Earnings Call Transcript ↗

May 10, 2021

TGTX earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Recap: TG Therapeutics Q1 Earnings ↗

May 10, 2021

Shares of TG Therapeutics (NASDAQ:TGTX) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share were down 43.75% year over year to...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

All News about TG Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today